# Diets and eating patterns in mucopolysaccharidosis
In mucopolysaccharidosis (MPS), nutrition plays a supportive role, particularly because this rare genetic disease has significant effects on digestion, bone metabolism, and overall health. Available research on specific diets remains limited, and nutritional choices are primarily tailored to individual symptoms and treatment. Below is an overview of the diets and eating patterns found in research or practice in MPS.
Protein-rich nutrition
ResearchediPositive results in clinical studies, not yet standard treatment
An eating pattern with adequate protein intake has received attention because MPS patients often struggle with muscle wasting, growth delay, and bone involvement. Protein supports the building of muscle tissue and plays a role in bone formation — both processes that can be affected in MPS.
However, no standard protein protocol has been established for MPS. Research on bone health and bone mineralization (2026) shows that many MPS patients develop osteopenia or osteoporosis, part of their metabolic challenges. Adequate protein intake is considered supportive, but has never been proven as a cure or as a replacement for enzyme therapy.
**Risks:** In certain MPS types (especially type III), digestion is sometimes difficult; large amounts or heavy protein-rich food can cause additional gastrointestinal problems. Patients should discuss this on a case-by-case basis with their clinician.
Calcium-rich food and vitamin D
ResearchediPositive results in clinical studies, not yet standard treatment
Given the frequent bone involvement in MPS — including spinal collapse, loss of bone density, and growth delay — adequate intake of calcium and vitamin D receives regular attention. These substances are essential for bone mineralization and can help prevent bone loss.
Recent research (2026) on bone health shows that many MPS patients are placed under the supervision of enzyme therapy, with regular monitoring of their bone density. Vitamin D and calcium status are usually checked in that care; appropriate intake is generally recommended, but there are no specific MPS guidelines for amounts.
**Risks:** An excess of calcium can cause interference with certain kidney-supportive treatments; this should be coordinated with the treatment team.
Diet low in certain sugars (substrate reduction)
ExperimentaliOngoing in study setting, outcome still unknown
Because MPS develops through the accumulation of certain complex sugars (polysaccharides and oligosaccharides) in cells, researchers have investigated whether limiting the intake of these substances — called substrate reduction — could relieve symptoms. A small animal study (2022) showed that flaxseed extract in rats could reduce the tissue accumulation of chondroitin sulfate (one of the substances that accumulates in MPS) and increase its excretion.
However, this research is still in a very early stage. There are no clinical trials in human patients and no established dietary interventions. This approach is being studied primarily by research groups and is not suitable for self-application.
**Risks:** Attempting to restrict food on your own based on these studies can lead to malnutrition, especially in children with MPS who already experience growth delay.
Spermidine supplementation
ExperimentaliOngoing in study setting, outcome still unknown
Spermidine is a natural substance found in many foods (such as wheat germ, mature cheese, pineapple). Recent animal studies (2026) suggest that oral spermidine administration might affect certain aspects of MPS type III (Sanfilippo syndrome) — a form with severe neurological involvement — through a process called autophagy (cellular 'cleanup').
However, this research is limited to flies and mice. There are still no safety or efficacy studies in patients. Spermidine supplementation is not on the treatment list and has not been demonstrated for MPS patients.
**Risks:** The use of supplements outside medical supervision can cause interference with enzyme therapy and warrants caution.
Water intake and fluid balance
ResearchediPositive results in clinical studies, not yet standard treatment
In various MPS types, fluid retention, ascites (fluid accumulation in the abdomen) and kidney problems can occur. Regular water intake and fluid balance are monitored in clinical care.
A case from 2023 described a newborn with MPS type VII who had intractable ascites — a situation where fluid balance was crucial. Adequate fluid intake, adjusted to kidney excretion and body fluid balance, is part of symptomatic support.
**Risks:** In some patients, excess fluid can lead to pulmonary congestion; in others, restriction is needed. This is strictly individual and must be continuously coordinated with the medical team.
Nutrition in gastroparesis and digestive problems
ResearchediPositive results in clinical studies, not yet standard treatment
MPS patients regularly have gastroparesis and gastrointestinal delayed transit, particularly type III patients with neurological involvement. Smaller, more frequent meals, lower fat intake and easily digestible foods are often recommended in practice.
This is not a diet in the strict sense, but rather adapted eating patterns that relieve gastrointestinal symptoms. Research on this topic is limited, but it is routinely applied by treating physicians.
**Risks:** Malnutrition and growth retardation are already risks in MPS; inappropriate dietary restriction can worsen this. A specialized dietitian can help find a balance.
Melamine and food allergy
ResearchediPositive results in clinical studies, not yet standard treatment
Patients with Hurler syndrome (MPS type I) and certain other forms can have hepatic involvement, including liver infections or inflammation. A recent case (2026) described a patient with Hurler syndrome who sustained liver damage from medications on top of hepatitis C infection.
Although not directly nutrition-related, this underscores the importance of caution with foods that can increase liver burden (fatty foods, certain additives). This requires individual adjustment.
**Risks:** With liver involvement, certain food components can further burden the liver.
---
Nutrition as personalized care
Dietary choices in mucopolysaccharidosis are strongly dependent on the MPS type, disease stage, treatment given (enzyme replacement, stem cell therapy) and individual symptoms. No single eating pattern is standard or proven for all patients.
It is essential to always coordinate nutrition with the treating physician and ideally with a dietitian who has experience with metabolic diseases. Nutrition can relieve symptoms — such as better digestion, better bone health or less liver burden — but cannot correct the underlying genetic disorder.
_This information never replaces a physician's judgment. Always discuss your nutritional choices with your own healthcare provider._